X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/first-patient-treated-in-phase-2-gvhd-trial-302079209.html
https://www.prnewswire.com/news-releases/encouraging-initial-data-from-cyp-006tk-diabetic-foot-ulcer-clinical-trial-302070709.html
https://www.prnewswire.com/news-releases/us-fda-clears-ind-for-cynatas-phase-2-clinical-trial-of-cyp-001-in-gvhd-301555847.html
https://thewest.com.au/business/public-companies/cynata-secures-manufacturing-deal-for-breakthrough-biotech-c-5119020
https://thewest.com.au/business/public-companies/cynata-clocks-up-more-patents-for-stem-cell-technology-c-3973426
https://www.clinicaltrialsarena.com/news/cynata-expand-recruitment-criteria/
http://www.globenewswire.com/news-release/2021/03/29/2200737/0/en/Cynata-Expands-MEND-clinical-trial-in-COVID-19-and-Respiratory-Failure.html#:~:text=The%20approved%20expansion%20will%20enable,19%20no%20longer%20a%20requirement.&text=The%20MEND%20trial%20is%20an,in%20patients%20with%20respiratory%20failure.
https://www.globenewswire.com/fr/news-release/2021/03/01/2184226/0/en/Cynata-Advances-Planned-Clinical-Trial-in-Diabetic-Foot-Ulcers-in-MoU-With-TekCyte.html
Market Place
Share 
